Skip to main content
. 2019 Oct 25;11(11):1649. doi: 10.3390/cancers11111649

Figure 4.

Figure 4

Kaplan–Meier Plots describing overall survival for patients with a level of methylated circulating tumor (ct) DNA above or below the median. Median survival was 7.6 vs. 4.3 months, p < 0.001.